Global Hemostasis Testing Systems Market By Application (Acquired Bleeding Disorders, Congenital Bleeding Disorders); By Product (Laboratory systems, Consumables, Point-of-care testing systems); By End-User (Hospitals, Clinics, Academic Institutions, Diagnostic Laboratories) - Global Demand Analysis & Opportunity Outlook 2027

  • Report ID: 901
  • Published Date: Feb 09, 2023
  • Report Format: PDF, PPT

Global Hemostasis Testing Systems Market Overview

Hemostasis is the physiological phenomenon that prevents bleeding at the spot of injury while retaining usual blood flow everywhere else in the circulation. Blood loss is stopped by formation of a hemostatic plug. The endothelium in blood vessels maintains an anticoagulant surface that serves to maintain blood in its fluid state, but if the blood vessel is damaged components of the sub-endothelial matrix are exposed to the blood. Several of these components activate the two main processes of hemostasis to initiate formation of a blood clot, composed primarily of platelets and fibrin. This process is tightly regulated such that it is activated within seconds of an injury but must remain localized to the site of injury. It is problematic to achieve hemostasis when the body is under stress or shock. While natural hemostasis is the most preferred way of wound curing, in cases of emergencies artificial means of achieving hemostasis becomes essential. Malfunctioning or a delay of natural body hemostasis may be life threatening or can cause hemorrhages. As a result, an artificial method of hemostasis in cases of absence of natural body hemostasis is vital.

Market Size & Forecast

Hemostasis testing systems market is anticipated to record a significant CAGR over the forecast period. Many multi-national companies are focusing towards new product advances to bolster their product portfolio in hemostasis testing systems. These systems are semi-automated or automated that are intended for fibrinolysis diagnostic testing for reviewing thrombosis and hemostasis; and in-vitro coagulation.

Hemophilia, a bleeding disorder is characterized by inadequate hemostasis. The over activity of blood clotting also causes difficulties such as thrombosis in which blood clots are developed enormously and abnormally ensuing into the formation of emboli. The condition in which blood clots break off and enter the veins or arteries is called embolism. These kind of disorders associated to hemostasis are rising owing to which the global hemostasis testing systems market is estimated to grow at a robust rate. On the basis of regional platform, global hemostasis testing systems market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. 

Hemostasis Testing Systems Market Size

                         Get more information on this report: Download Sample PDF

North America holds the leading share in the hemostasis testing systems market owing to high prevalence of cardiac diseases, high healthcare expenditure, growing awareness for hemostasis diagnostics and well-established healthcare infrastructure which act as certain aspects credited to the growth of the market in North America. In 2014 America & Europe together held more than half the shares in the global hemostasis testing systems market.

Asia Pacific is anticipated to surpass all other regions in terms of growth owing to increasing income levels in the emerging economies of China and India is leading to increased healthcare spending. Moreover, changing lifestyles have led to the proliferation of lifestyle related diseases such as cancer, diabetes, and heart disease. Therefore, research initiatives and the subsequent funds in the biopharmaceutical sector have intensified in the region. Further, government initiatives for the development of healthcare infrastructure, and rising shift in base of pharmaceutical companies and clinical research agencies from developed regions to developing regions bodes well for Asia Pacific hemostasis testing devices market.

Market Segmentation

Our-in depth analysis of the global hemostasis testing systems market includes the following segments:

By Application

  • Acquired Bleeding Disorders
  • Congenital Bleeding Disorders
    • Hemophilia
    • Von Willebrand Disease

By Product

  • Laboratory systems
  • Consumables
  • Point-of-care testing systems

By End-User

  • Hospitals
  • Clinics
  • Academic Institutions
  • Diagnostic Laboratories

By Region

Global hemostasis testing systems Market is further classified on the basis of region as follows:

  • North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis

Hemostasis Testing Systems Market Share

Growth Drivers & Challenges

The global hemostasis testing systems market is propelled by the escalating requirement in cases of acute blood loss during severe injuries. Also, hemostatic agents are known to be the key instruments for wound healing after bleeding through small injuries. Hemostasis testing systems help in the whole blood hemostasis testing and further offer comprehensive report concerning the risks, and observe the applicable therapies. Hemostasis testing systems provide a complete picture of the essential directed treatment for different disorders and conditions of patient.

However, absence of incursion into the price sensitive developing regions could possibly hinder the growth of global hemostasis testing systems market. Also, the global hemostasis testing systems market growth is restricted by the inefficiency of hemostatic agents in chronic bleeding patient cases.

Top Featured Companies Dominating The Market

  • Medtronic
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Haemonetics Corporation
  • Roche Diagnostics Limited
  • Sysmex
  • Abbott Laboratories
  • Thermo fisher Scientific Inc.
  • Alere Inc.
  • Siemens Healthineers
  • Instrumentation Laboratory


In the News

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 901
  • Published Date: Feb 09, 2023
  • Report Format: PDF, PPT

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying